Embracing the Landscape of Therapeutics.
出版信息
Cell. 2020 Apr 2;181(1):1-3. doi: 10.1016/j.cell.2020.03.025.
Abstract
摘要
相似文献
1
Embracing the Landscape of Therapeutics.拥抱治疗学领域
Cell. 2020 Apr 2;181(1):1-3. doi: 10.1016/j.cell.2020.03.025.
2
Drug-drug similarity measure and its applications.药物相似性度量及其应用。
Brief Bioinform. 2021 Jul 20;22(4). doi: 10.1093/bib/bbaa265.
3
In silico drug repositioning: from large-scale transcriptome data to therapeutics.计算机药物重定位：从大规模转录组数据到治疗学。
Arch Pharm Res. 2019 Oct;42(10):879-889. doi: 10.1007/s12272-019-01176-3. Epub 2019 Sep 3.
4
Changes on the Horizon for Drug Repurposing, Rescue, and Repositioning at ASSAY.药物重新利用、救援及重新定位在分析中的新变化
Assay Drug Dev Technol. 2018 May/Jun;16(4):193. doi: 10.1089/adt.2018.29074.edi. Epub 2018 Jun 5.
5
The Drug Repurposing Hub: a next-generation drug library and information resource.药物再利用中心：一个新一代药物库及信息资源。
Nat Med. 2017 Apr 7;23(4):405-408. doi: 10.1038/nm.4306.
6
Relating anatomical therapeutic indications by the ensemble similarity of drug sets.通过药物集的整体相似度来关联解剖治疗指征。
J Chem Inf Model. 2013 Aug 26;53(8):2154-60. doi: 10.1021/ci400155x. Epub 2013 Aug 12.
7
Assessing the public landscape of clinical-stage pharmaceuticals through freely available online databases.通过免费的在线数据库评估临床阶段药物的公共领域情况。
Drug Discov Today. 2019 Apr;24(4):1010-1016. doi: 10.1016/j.drudis.2019.01.010. Epub 2019 Jan 25.
8
A Prospective Overview of Drug Repurposing in Drug Discovery and Development.药物发现与开发中药物再利用的前瞻性概述。
Curr Med Chem. 2019;26(28):5338-5339. doi: 10.2174/092986732628191025094454.
9
Editorial: computational methods for drug repurposing.社论：药物重新利用的计算方法
Brief Bioinform. 2011 Jul;12(4):301-2. doi: 10.1093/bib/bbr047.
10
Drug repurposing a reality: from computers to the clinic.药物重新利用成为现实：从计算机到临床。
Expert Rev Clin Pharmacol. 2013 Mar;6(2):95-7. doi: 10.1586/ecp.12.79.
引用本文的文献
1
SARS-CoV-2 Virus and Human Leukocyte Antigen (HLA) Class II: Investigation in silico of Binding Affinities for COVID-19 Protection and Vaccine Development.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与人类白细胞抗原（HLA）II类：针对新冠病毒疾病（COVID-19）防护和疫苗开发的结合亲和力的计算机模拟研究
J Immunol Sci. 2020 Nov 16;4(4):12-23. doi: 10.29245/2578-3009/2020/4.1198.
2
Natural medicinal plant products as an immune-boosters: A possible role to lessen the impact of Covid-19.天然药用植物产品作为免疫增强剂：减轻新冠疫情影响的潜在作用。
Case Stud Chem Environ Eng. 2021 Dec;4:100105. doi: 10.1016/j.cscee.2021.100105. Epub 2021 May 5.
3
Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2.针对 SARS-CoV-2 新变体的病毒和细胞半胱氨酸蛋白酶靶向治疗。
Viruses. 2024 Feb 22;16(3):338. doi: 10.3390/v16030338.
4
Current Healthcare Systems in Light of Hyperendemic NCDs and the COVID-19 Pandemic: Time to Change.鉴于高流行率的非传染性疾病和新冠疫情的当前医疗保健系统：是时候做出改变了。
Healthcare (Basel). 2023 May 10;11(10):1382. doi: 10.3390/healthcare11101382.
5
Multi-target antibacterial mechanism of ruthenium polypyridine complexes with anthraquinone groups against .含蒽醌基团的钌多吡啶配合物对……的多靶点抗菌机制
RSC Med Chem. 2023 Feb 7;14(4):700-709. doi: 10.1039/d2md00430e. eCollection 2023 Apr 26.
6
Medicine and health of 21st Century: Not just a high biotech-driven solution.21世纪的医学与健康：不仅仅是由高科技驱动的解决方案。
NPJ Genom Med. 2022 Nov 15;7(1):67. doi: 10.1038/s41525-022-00336-7.
7
Perspective of AI system for COVID-19 detection using chest images: a review.基于胸部图像的COVID-19检测人工智能系统综述
Multimed Tools Appl. 2022;81(15):21471-21501. doi: 10.1007/s11042-022-11913-4. Epub 2022 Mar 15.
8
The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population - Public Health Implications.新冠疫情与老年人群多重用药的双重负担——对公共卫生的影响
Ther Clin Risk Manag. 2020 Oct 20;16:1007-1022. doi: 10.2147/TCRM.S272908. eCollection 2020.
9
Repurposing existing drugs for COVID-19: an endocrinology perspective.重新利用现有药物治疗 COVID-19：内分泌学视角。
BMC Endocr Disord. 2020 Sep 29;20(1):149. doi: 10.1186/s12902-020-00626-0.
10
SARS-CoV-2 envelope protein topology in eukaryotic membranes.真核细胞膜中的 SARS-CoV-2 包膜蛋白拓扑结构。
Open Biol. 2020 Sep;10(9):200209. doi: 10.1098/rsob.200209. Epub 2020 Sep 9.
Zotero 插件